Imatinib (Gleevec (R))) Maintains Favorable Long-Term Outcomes In Chronic-Phase Chronic Myeloid Leukemia (Cml) For Patients Failing Interferon-Alpha (Ifn) - Follow-Up Of A Phase Ii Study.Hm Kantarjian,Ca Schiffer,Cl Sawyers,A Hochhaus,F Guilhot, Dw Niederwieser, C Gambacorti,Rm Stone,Jm Goldman,T Fischer,J Reiffers,S O'Brien,Bd Smith, Ms Tallmann,Ra Brown,Rt Silver,A Gratwohl,C So,I Gathmann, Ml Hensley,Bj DrukerBLOOD（2003）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
